Literature DB >> 29575364

Unilateral pain and shorter duration of chronic migraine are significant predictors of response to onabotulinumtoxin A.

C Domínguez1, P Pozo-Rosich2, Y Leira3, R Leira1.   

Abstract

Entities:  

Keywords:  chronic migraine; early treatment; effectiveness; onabotulinumtoxin A; predictors

Mesh：

Substances：

Year:  2018        PMID： 29575364     DOI： 10.1111/ene.13570

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  3 in total

1.  Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine-A Real-Life Study.

Authors:  Magdalena Nowaczewska; Marcin Straburzyński; Marta Waliszewska-Prosół; Grzegorz Meder; Joanna Janiak-Kiszka; Wojciech Kaźmierczak
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

2.  Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors.

Authors:  Raffaele Ornello; Carlo Baraldi; Fayyaz Ahmed; Andrea Negro; Anna Maria Miscio; Antonio Santoro; Alicia Alpuente; Antonio Russo; Marcello Silvestro; Sabina Cevoli; Nicoletta Brunelli; Fabrizio Vernieri; Licia Grazzi; Luca Pani; Anna Andreou; Giorgio Lambru; Ilaria Frattale; Katharina Kamm; Ruth Ruscheweyh; Marco Russo; Paola Torelli; Elena Filatova; Nina Latysheva; Anna Gryglas-Dworak; Marcin Straburzyński; Calogera Butera; Bruno Colombo; Massimo Filippi; Patricia Pozo-Rosich; Paolo Martelletti; Simona Guerzoni; Simona Sacco
Journal:  Int J Environ Res Public Health       Date:  2022-09-02       Impact factor: 4.614

3.  Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data.

Authors:  Raffaele Ornello; Simona Guerzoni; Carlo Baraldi; Luana Evangelista; Ilaria Frattale; Carmine Marini; Cindy Tiseo; Francesca Pistoia; Simona Sacco
Journal:  J Headache Pain       Date:  2020-04-25       Impact factor: 7.277
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.